Tests For Ovarian Cancer Can Backfire

Tests for ovarian cancer can backfire

In healthy women, screening for the deadly malignancy actually does more harm than good, a study shows.

Sections:  living   
Topics:  cancer   early detection   health   ovarian cancer   women   
RELATED ARTICLES
  • Most people aren't meeting exercise guidelines
    Most adults in the USA aren't meeting the federal physical activity recommendations for both aerobic exercise and muscle-strengthening activity, according to government statistics out today. About 79% of adults don't meet the physical activity guidelines that advise getting at least 2½ hours a week of moderate-intensity aerobic activity such as brisk walking, or one hour and 15 minutes a week of vigorous-intensity aerobic activity, such as jogging. More
  • US suicide rate rose sharply among middle-aged
    Health officials say suicides among middle-aged Americans climbed at a startling rate over the past decade, a period that included the recession. Overall, the suicide rate for the age group jumped 28 percent from 1999 to 2010. And among whites, it shot up 40 percent.... More
  • Cost of feeding a family of four: $146 to $289 a week
    Latest statistics give a range of prices for feeding a family of four a healthy diet. The cost of feeding a family of four a healthy diet can run $146 to $289 a week, according to the latest numbers from the U.S. More
  • 2-year-old girl gets windpipe made from stem cells
    A 2-year-old girl born without a windpipe now has a new one grown from her own stem cells, the youngest patient in the world to benefit from the experimental treatment.... More
  • Study: New bird flu jumped directly from chickens
    Chinese scientists have for the first time found strong evidence of how humans got infected with a new strain of bird flu: from chickens at a live market. In a small study of four patients who caught the new H7N9 virus, Chinese scientists compared swabs from birds at live markets in eastern China to virus samples from patients. More
BING NEWS:
  • Potential dangers of direct-to-consumer genetic test for cancer risk
    A new editorial was published in Oncotarget's Volume 15 on December 24, 2024, titled "Pitfalls and perils from FDA-approved germ-line cancer predisposition tests." ...
    12/30/2024 - 12:54 pm | View Link
  • Verastem Oncology Announces FDA Acceptance and Priority Review of New Drug Application for Avutometinib in Combination with Defactinib for the Treatment of Recurrent KRAS ...
    Verastem Oncology (Nasdaq: VSTM), a biopharmaceutical company committed to advancing new medicines for patients with cancer, today announced that the ...
    12/30/2024 - 12:29 pm | View Link
  • FDA accepts Verastem NDA for ovarian cancer drug combo
    Verastem (NASDAQ:VSTM) said the FDA has accepted its New Drug Application for accelerated approval of its drugs avutometinib and defactinib for the treatment of a certain type of ovarian cancer, with ...
    12/30/2024 - 9:40 am | View Link
  • Verastem Oncology's Ovarian Cancer Treatment Gets FDA Priority Review
    (RTTNews) - Biopharmaceutical company Verastem Oncology (VSTM) Monday said that its treatment for a rare form of ovarian cancer has been given priority review by the Food and Drug Administration.
    12/30/2024 - 4:37 am | View Link
  • Prostate Cancer: What men need to know and why early intervention is key!
    By Greg Nason Since 2003, Movember aims to raise awareness of men’s health for the month of November. Prostate cancer is the most common (non-cutaneous) cancer affecting men in Ireland, ...
    12/29/2024 - 2:00 am | View Link
  • More

 

Comment On This Story

Welcome to Wopular!

Welcome to Wopular

Wopular is an online newspaper rack, giving you a summary view of the top headlines from the top news sites.

Senh Duong (Founder)
Wopular, MWB, RottenTomatoes

Subscribe to Wopular's RSS Fan Wopular on Facebook Follow Wopular on Twitter Follow Wopular on Google Plus

MoviesWithButter : Our Sister Site

More Living News